Results 61 to 70 of about 89,416 (210)
Brazilian Journal of PsychiatryObjective: Due to the uncertainty whether atypical and typical antipsychotics have a stronger association with mortality among older people with schizophrenia, we examined the rates and causes of mortality in older adults with schizophrenia who take ...
Raphaëlle Haddad +7 more
doaj +1 more source
Attitudes of European physicians towards the use of long-acting injectable antipsychotics
BMC Psychiatry, 2020 Background Prescription rates for long-acting injectable (LAI) antipsychotic formulations remain relatively low in Europe despite improved adherence over alternative oral antipsychotic treatments.
Maxine X. Patel +6 more
doaj +1 more source
, 2021 Monica Zolezzi,1 Rawan Abouelhassan,1 Yassin Eltorki,2 Peter M Haddad,2 Mahtab Noorizadeh1 1College of Pharmacy, QU Health, Qatar University, Doha, Qatar; 2Mental Health Hospital, Hamad Medical Corporation, Doha, QatarCorrespondence: Monica ...
Eltorki Y +4 more
core
Atypical antipsychotics in bipolar disorder: systematic review of randomised trials
BMC Psychiatry, 2007 Background Atypical antipsychotics are increasingly used for treatment of mental illnesses like schizophrenia and bipolar disorder, and considered to have fewer extrapyramidal effects than older antipsychotics.
Moore R Andrew, Derry Sheena
doaj +1 more source
, 2014 Tardive dyskinesia (TD) is a disfiguring side-effect of antipsychotic medications that is potentially irreversible in affected patients. Newer atypical antipsychotics are felt by many to have a lower risk of TD.
Thomas L Schwartz +2 more
core +1 more source
Psychotropic medication use in Swiss nursing homes
Swiss Medical Weekly, 2011 BACKGROUND: Psychotropic medication is commonly used in nursing homes, to treat behavioural and psychological symptoms of dementia (BPSD) for example.
I Lustenberger, B Schüpbach
doaj +1 more source
, 2022 This article systemically reviews studies that present interventions related to pharmacological and non-pharmacological treatment for the weight management and reduction of pediatric patients prescribed antipsychotics.
Gaytan, Claudia
core
A comparison of depot and oral atypical antipsychotics in terms of metabolic syndrome markers
Psychiatry and Clinical Psychopharmacology, 2018 OBJECTIVES: The duration of life of patients with schizophrenia is shorter than that of the general population for various reasons. Especially cardiovascular diseases are one of the most important causes of death in patients with schizophrenia.
Demet Sağlam Aykut +1 more
doaj +1 more source
Leptin and psychiatric illnesses: does leptin play a role in antipsychotic-induced weight gain?
Lipids in Health and Disease, 2020 Antipsychotic-induced weight gain is the most prevalent somatic adverse event occurring in patients treated by antipsychotics, especially atypical antipsychotics.
Francky Teddy Endomba +3 more
doaj +1 more source